Sarepta Therapeutics, Inc. short interest in 2026
In 2026, Sarepta Therapeutics, Inc.'s disclosed short interest ran from 20.31% of shares outstanding on 15 Jan 2026 to 24.08% on 15 Sep 2026, a change of +3.77 percentage points. The year's high was 27.22% on 30 Jun 2026 and its low 20.27% on 27 Feb 2026, averaging 23.64% across 17 twice-monthly settlement dates. FINRA's days-to-cover figure peaked at 11.47 days on 15 Apr 2026. Full history: Sarepta Therapeutics, Inc..
Cite this page
By year: 2018 · 2019 · 2020 · 2021 · 2022 · 2023 · 2024 · 2025 · 2026
2026 in figures
- Start of year
- 20.31% (15 Jan 2026)
- End of year
- 24.08% (15 Sep 2026)
- Change
- +3.77 pp
- High
- 27.22% (30 Jun 2026)
- Low
- 20.27% (27 Feb 2026)
- Average
- 23.64%
- Highest days to cover
- 11.47 (15 Apr 2026)
- SEC filings marked
- 7
Every report in 2026
| Settlement | Short interest | Days to cover | Filings since previous |
|---|---|---|---|
| 15 Jan 2026 | 20.31% | 6.50 | results (8-K) |
| 30 Jan 2026 | 21.21% | 7.40 | |
| 13 Feb 2026 | 21.18% | 9.39 | |
| 27 Feb 2026 | 20.27% | 9.82 | results (8-K) |
| 13 Mar 2026 | 21.84% | 9.10 | 10-K filed |
| 31 Mar 2026 | 24.55% | 6.26 | |
| 15 Apr 2026 | 24.18% | 11.47 | |
| 30 Apr 2026 | 23.78% | 9.54 | |
| 15 May 2026 | 23.70% | 7.32 | 10-Q filed, results (8-K) |
| 29 May 2026 | 23.80% | 9.44 | |
| 15 Jun 2026 | 23.84% | 9.10 | |
| 30 Jun 2026 | 27.22% | 5.75 | |
| 15 Jul 2026 | 26.98% | 9.22 | |
| 31 Jul 2026 | 26.10% | 8.77 | |
| 14 Aug 2026 | 25.61% | 9.07 | 10-Q filed, results (8-K) |
| 31 Aug 2026 | 23.31% | 8.46 | |
| 15 Sep 2026 | 24.08% | 8.02 |
See also: Sarepta Therapeutics, Inc.'s full history · today's US league.
About this data
US short interest data: FINRA (finra.org), shown as reported shares short divided by SEC-reported shares outstanding for each settlement date. FINRA® is a registered trademark of the Financial Industry Regulatory Authority, Inc. This site is not affiliated with or endorsed by FINRA or the SEC; displayed for personal reference, bulk redistribution is not permitted (see terms). Nothing here is investment advice. Method: methodology.